Lantern Pharma Inc.

Q2 2026 13F Holders

Symbol
LTRN
CUSIP
51654W101
Type
Equity
Class
COM
Num filings
39
Total reported value, excl. options
$12.0 M
Manager Report Date Value ($000) Shares Option Type